X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Health & Nutrition

SternLife debuts with brand new clinical nutrition concepts CPhI 2019, booth 90B12: innovative products for suppliers of medical nutrition

Content Team by Content Team
16th September 2019
in Health & Nutrition, Press Statements
SternLife innovative products for suppliers of medical nutrition

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

SternLife, a renowned supplier of private label functional foods, will exhibit at CPhI Worldwide for the first time. The company will showcase a portfolio of six supplementary and seven nutritionally complete medical foods for the prevention of malnourishment. Ideal for nutritional therapies in hospitals, care homes and other medical facilities, the portfolio includes bars, powders and thickening agents. Aimed at helping companies establish or expand their private label clinical nutrition offerings, SternLife provides full service assistance – from the first concept and formulation development to production and advice on food legislation.

A good supply of nutrients is a key factor in the care of all patients. Often however they are unable to obtain everything they need from a regular diet. Targeted clinical nutrition based on well thought-out dietary treatment concepts is therefore required. With its innovative range of customised products, SternLife supports suppliers who are unable to develop these themselves.

During the trade fair, the company will present various patient-oriented products, such as bars, powders for shakes, high-calorie admixture powders, and thickening agents that increase the viscosity of foods for patients with swallowing difficulties. All of these products can help to prevent malnutrition. The new supplements complement the diet with specially selected macro- and micro-nutrients. For patients who are unable to eat in the normal way, SternLife also offers high-protein, fibre-rich nutritionally complete medical foods. In addition, its portfolio includes supplementary products for those with kidney problems.

supplementary and fully balanced foods, which we will showcase for the first time at CPhI. As an experienced partner for innovative clinical nutrition products, we support our customers from the very first idea. We develop tailor-made formulations and produce products at our state-of-the-art facilities in Germany, where the highest standards are met. Our long-standing experience in nutrition also means we are able to give advice on packaging and food legislation – from nutritional information to the necessary declarations.”

About SternLife
SternLife GmbH & Co. KG develops and manufactures functional foods and food supplements. The portfolio ranges from powder preparations, functional bars and snacks to capsules and tablets. Brands and private labels benefit from our comprehensive know-how in the innovative health, sport and lifestyle nutrition sector and from the range of products tailored to specific target groups. SternLife is a member of the independent, owner-managed Stern-Wywiol Gruppe, one of the most successful enterprises with international operations in the world of food and feed ingredients. When developing new products, the functional food experts have access to the pooled skills of eleven specialist companies and some 100 R&D experts in the Stern Technology Centre with its broad range of applications technology. SternLife products are made in the group’s own state-of-the-art manufacturing facilities located in various parts of Germany.

Antje Wetzel, Head of Product Development at SternLife, explains: “The clinical nutrition segment is a good fit for our expertise and our portfolio of high-quality bars and powder products with added value. For this reason, we have developed a special range of supplementary and fully balanced foods, which we will showcase for the first time at CPhI. As an experienced partner for innovative clinical nutrition products, we support our customers from the very first idea. We develop tailor-made formulations and produce products at our state-of-the-art facilities in Germany, where the highest standards are met. Our long-standing experience in nutrition also means we are able to give advice on packaging and food legislation – from nutritional information to the necessary declarations.”

About SternLife
SternLife GmbH & Co. KG develops and manufactures functional foods and food supplements. The portfolio ranges from powder preparations, functional bars and snacks to capsules and tablets. Brands and private labels benefit from our comprehensive know-how in the innovative health, sport and lifestyle nutrition sector and from the range of products tailored to specific target groups. SternLife is a member of the independent, owner-managed Stern-Wywiol Gruppe, one of the most successful enterprises with international operations in the world of food and feed ingredients. When developing new products, the functional food experts have access to the pooled skills of eleven specialist companies and some 100 R&D experts in the Stern Technology Centre with its broad range of applications technology. SternLife products are made in the group’s own state-of-the-art manufacturing facilities located in various parts of Germany.

Previous Post

Roxadustat approved in China for the treatment of anaemia in non-dialysis-dependent patients with chronic kidney disease

Next Post

Catalent To Open New Clinical Supply Facility In San Diego

Related Posts

Packaging & Logistic

VarioFill: Rotzinger sets new standards with highly flexible filling and capping platform for OTC products

30th August 2025
Major Depressive Disorder
Americas

AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

27th August 2025
Schott-Testing
Press Statements

Carbon Reduced Pharmaceutical Glass: SCHOTT Melting Tank Construction Starts and External Certification for FIOLAX® Pro OCF

11th August 2025
GSK and Hengrui Pharma
Drug Development

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

29th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
Pharma Advancement Banner
Press Statements

Welcome to the Inaugural Operationalize: Expanded Access Programs Summit West

27th June 2025
Next Post
Catalent To Open New Clinical Supply Facility In San Diego

Catalent To Open New Clinical Supply Facility In San Diego

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In